1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow DIPG: new trials by email Literature Review of DIPG trials Research Report on DIPG
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prolonged Exposure to Doxorubicin in Patients With Glioblastoma Multiforme and Diffuse Intrinsic Pontine Glioma Doxorubicin - Glioblastoma (GBM), DIPG | Phase 2 | Terminated | Meyer Children's Hospital IRCCS | 21 | 2016-02-01 | 2021-02-09 |
Astrocytoma (1) · Diffuse Intrinsic Pontine Glioma (1) · Glioblastoma (1) · Glioma (1) · Neoplasms, Neuroepithelial (1)
Brain Diseases (1) · Brain Neoplasms (1) · Brain Stem Neoplasms (1) · Central Nervous System Diseases (1) · Central Nervous System Neoplasms (1) · Infratentorial Neoplasms (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Glandular and Epithelial (1) · Neoplasms, Nerve Tissue (1) · Nervous System Diseases (1) · Nervous System Neoplasms (1) · Neuroectodermal Tumors (1)
Doxorubicin (1)
Meyer Children's Hospital IRCCS (1)
Italy (1)
2015 (1)